Home/Filings/4/0001225208-19-013992
4//SEC Filing

Hartman John T. 4

Accession 0001225208-19-013992

CIK 0000033185other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 4:13 PM ET

Size

11.9 KB

Accession

0001225208-19-013992

Insider Transaction Report

Form 4
Period: 2019-10-30
Transactions
  • Exercise/Conversion

    Common Stock

    2019-10-30$37.53/sh+7,500$281,47531,143 total
  • Exercise/Conversion

    Stock Option/Right to Buy

    2019-10-307,5000 total
    Exercise: $37.53Exp: 2021-04-29Common Stock (7,500 underlying)
  • Sale

    Common Stock

    2019-10-30$134.12/sh772$103,54330,343 total
  • Sale

    Common Stock

    2019-10-30$135.00/sh8,963$1,210,03721,380 total
  • Sale

    Common Stock

    2019-10-30$136.07/sh28$3,81031,115 total
Footnotes (5)
  • [F1]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019.
  • [F3]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $133.54 to $134.525, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  • [F4]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $134.63 to $135.31, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
  • [F5]The option vested in three equal annual increments beginning 4/12/2012.

Documents

1 file

Issuer

EQUIFAX INC

CIK 0000033185

Entity typeother

Related Parties

1
  • filerCIK 0001431075

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:13 PM ET
Size
11.9 KB